Sarosdy, M F <br/><br/>
Does prolonged combined androgen blockade have survival benefits over short-term combined androgen blockade therapy?  [electronic resource] 

 -  Urology  Mar 2000 
 - 391-5; discussion 395-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-9995 
<br/><br/><label>Standard No.: </label>10.1016/s0090-4295(99)00574-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Androgen Antagonists--administration & dosage<br/>Anilides--administration & dosage<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Flutamide--administration & dosage<br/>Gonadotropin-Releasing Hormone--agonists<br/>Goserelin--administration & dosage<br/>Humans<br/>Leuprolide--administration & dosage<br/>Male<br/>Middle Aged<br/>Nitriles<br/>Prostatic Neoplasms--drug therapy<br/>Survival Rate<br/>Tosyl Compounds